Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: A multicenter study
Craig I. Coleman, Paul P. Dobesh, Sherry Danese, Julie Ulloa, Belinda Lovelace
Dive into the research topics of 'Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: A multicenter study'. Together they form a unique fingerprint.